NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 169 filers reported holding NOVAVAX INC in Q1 2015. The put-call ratio across all filers is 2.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $11,000 | -8.3% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $12,000 | -7.7% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $13,000 | -38.1% | 10,000 | 0.0% | 0.00% | -50.0% |
| Q3 2016 | $21,000 | -71.2% | 10,000 | 0.0% | 0.00% | -69.2% |
| Q2 2016 | $73,000 | +40.4% | 10,000 | 0.0% | 0.01% | +18.2% |
| Q1 2016 | $52,000 | -38.1% | 10,000 | 0.0% | 0.01% | -38.9% |
| Q4 2015 | $84,000 | +18.3% | 10,000 | 0.0% | 0.02% | +12.5% |
| Q3 2015 | $71,000 | -36.0% | 10,000 | 0.0% | 0.02% | -33.3% |
| Q2 2015 | $111,000 | +33.7% | 10,000 | 0.0% | 0.02% | +33.3% |
| Q1 2015 | $83,000 | -29.7% | 10,000 | -50.0% | 0.02% | +38.5% |
| Q4 2014 | $118,000 | – | 20,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alden Global Capital LLC | 600,000 | $4,362,000 | 3.76% |
| DAFNA Capital Management LLC | 550,000 | $3,999,000 | 3.17% |
| BB BIOTECH AG | 8,330,000 | $60,559,000 | 2.39% |
| HARVEY CAPITAL MANAGEMENT INC | 602,750 | $4,381,000 | 2.20% |
| NORTHPOINTE CAPITAL LLC | 2,124,035 | $15,442,000 | 1.82% |
| Cormorant Asset Management, LP | 1,619,608 | $11,775,000 | 1.67% |
| WILLIAM HARRIS INVESTORS INC | 667,922 | $4,856,000 | 1.22% |
| Eventide Asset Management | 2,179,700 | $15,846,000 | 0.97% |
| SECTORAL ASSET MANAGEMENT INC | 912,305 | $6,632,000 | 0.68% |
| Rock Springs Capital Management LP | 852,500 | $6,198,000 | 0.46% |